CollPlant Ltd (CLGN) - Medical Equipment - Deals and Alliances Profile

CollPlant Ltd (CLGN) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME15401D
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant's wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant provides tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company also provides surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Ness Ziona, Israel.

CollPlant Ltd (CLGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

CollPlant Ltd, Medical Equipment, Deal Details 11

Partnerships 11

Lung Biotechnology Enters into Licensing Agreement with CollPlant 11

CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 12

CollPlant Enters into Distribution Agreement with Arthrex 13

CollPlant to Enter into Agreement with US based company 14

Equity Offering 15

CollPlant Raises USD2 Million in First Tranche of Private Placement 15

CollPlant to Raise Funds through Private Placement Shares and Warrants 16

CollPlant Raises USD1.9 Million in Equity Offering 17

CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 18

CollPlant Raises USD3 Million in Equity Offering 19

CollPlant Raises USD2 Million in Private Placement of Shares 20

CollPlant Raises USD2.3 Million in Private Placement of Shares 21

CollPlant Ltd-Key Competitors 22

CollPlant Ltd-Key Employees 23

CollPlant Ltd-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Strategy And Business Planning 25

Oct 23, 2018: CollPlant licences 3D bioprinting technology to United Therapeutics 25

Apr 23, 2018: CollPlant Opens New rhCollagen Production Facility In Israel 26

May 11, 2017: CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues 27

Financial Announcements 28

Sep 29, 2018: Collplant reports third quarter 2018 financial results and provides business update 28

Sep 21, 2018: CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update 30

May 24, 2018: CollPlant Announces First Quarter 2018 Financial Results 31

Mar 21, 2018: CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update 33

Corporate Communications 35

Jul 05, 2018: CollPlant Names Dr. Wolfgang Ruttenstorfer As Board Director 35

Jun 19, 2018: CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board 36

Apr 12, 2018: CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer 37

Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 38

Legal and Regulatory 39

Jun 26, 2018: CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs 39

Product News 40

May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler 40

Oct 30, 2017: Innovation Authority Gives Vote of Confidence: CollPlant Receives Innovation Authority Approval for USD One Million R&D Program with 40% Funding 41

Other Significant Developments 42

Feb 21, 2018: CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs 42

Nov 28, 2017: CollPlant Receives Substantial, Repeat Order for Its Biological Ink 43

May 31, 2017: CollPlant Provides Operational Update for Q1 2017 44

Mar 30, 2017: CollPlant Provides Commercial and Operational Update 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

CollPlant Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CollPlant Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CollPlant Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

CollPlant Ltd, Medical Equipment, Key Facts, 2017 2

CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

CollPlant Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

CollPlant Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

CollPlant Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

CollPlant Ltd, Deals By Market, 2012 to YTD 2018 9

CollPlant Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Lung Biotechnology Enters into Licensing Agreement with CollPlant 11

CollPlant Enters into Distribution Agreement for Vergenix FG in Turkey 12

CollPlant Enters into Distribution Agreement with Arthrex 13

CollPlant to Enter into Agreement with US based company 14

CollPlant Raises USD2 Million in First Tranche of Private Placement 15

CollPlant to Raise Funds through Private Placement Shares and Warrants 16

CollPlant Raises USD1.9 Million in Equity Offering 17

CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 18

CollPlant Raises USD3 Million in Equity Offering 19

CollPlant Raises USD2 Million in Private Placement of Shares 20

CollPlant Raises USD2.3 Million in Private Placement of Shares 21

CollPlant Ltd, Key Competitors 22

CollPlant Ltd, Key Employees 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

CollPlant Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17500
Site License
USD 500 INR 35000
Corporate User License
USD 750 INR 52500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com